BIO 2016 Notebook: Dealmaking, Reputation, Thailand And Boehringer Beyond Borders
Executive Summary
During the final days of the BIO International Convention, we heard about trends in biopharma deals for 2016, a call to arms for individuals to do more to communicate the industry's positive impact, and anticipated reforms in Thailand.
You may also be interested in...
Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth
Big pharma investments in early innovation are paying off in ways that still are hard to measure in any concrete way, but green shoots are sprouting through the pavement as startups supported by multimillion-dollar initiatives evolve from concept to reality.
BIO 2016 Notebook: Pricing And Innovation Hot Topics In San Francisco
Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.